Evidence has shown the association of elevated Fib levels with worse survival outcomes in gastrointestinal stromal tumors, pancreatic ductal adenocarcinoma, the coronavirus disease-19 (COVID-19), and colon cancer [32–35]. Here, FBL is linked to gastrointestinal stromal tumor.